Prelude Therapeutics, Inc. (PRLD)
4.70
-0.17
(-3.49%)
USD |
NASDAQ |
Sep 21, 16:00
4.73
+0.03
(+0.64%)
After-Hours: 20:00
Prelude Therapeutics Price to Book Value : 2.803 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 2.803 |
| September 18, 2026 | 2.904 |
| September 17, 2026 | 2.726 |
| September 16, 2026 | 2.666 |
| September 15, 2026 | 2.696 |
| September 14, 2026 | 2.737 |
| September 11, 2026 | 2.737 |
| September 10, 2026 | 2.785 |
| September 09, 2026 | 3.036 |
| September 08, 2026 | 3.161 |
| September 04, 2026 | 3.256 |
| September 03, 2026 | 3.131 |
| September 02, 2026 | 3.238 |
| September 01, 2026 | 3.274 |
| August 31, 2026 | 3.340 |
| August 28, 2026 | 3.262 |
| August 27, 2026 | 3.781 |
| August 26, 2026 | 3.912 |
| August 25, 2026 | 3.930 |
| August 24, 2026 | 3.859 |
| August 21, 2026 | 3.954 |
| August 20, 2026 | 3.876 |
| August 19, 2026 | 3.447 |
| August 18, 2026 | 3.429 |
| August 17, 2026 | 3.358 |
| Date | Value |
|---|---|
| August 14, 2026 | 3.31 |
| August 13, 2026 | 3.197 |
| August 12, 2026 | 3.417 |
| August 11, 2026 | 3.173 |
| August 10, 2026 | 2.881 |
| August 07, 2026 | 2.922 |
| August 06, 2026 | 2.791 |
| August 05, 2026 | 2.708 |
| August 04, 2026 | 2.696 |
| August 03, 2026 | 2.618 |
| July 31, 2026 | 2.743 |
| July 30, 2026 | 3.012 |
| July 29, 2026 | 2.809 |
| July 28, 2026 | 2.767 |
| July 27, 2026 | 2.32 |
| July 24, 2026 | 2.284 |
| July 23, 2026 | 2.344 |
| July 22, 2026 | 2.341 |
| July 21, 2026 | 2.409 |
| July 20, 2026 | 2.421 |
| July 17, 2026 | 2.505 |
| July 16, 2026 | 2.493 |
| July 15, 2026 | 2.660 |
| July 14, 2026 | 2.618 |
| July 13, 2026 | 2.648 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Q32 Bio, Inc. | 2.347 |
| Intellia Therapeutics, Inc. | 2.351 |
| Twist Bioscience Corp. | 23.32 |
| Beam Therapeutics, Inc. | 2.444 |
| Revolution Medicines, Inc. | 15.85 |
Price to Book Value Related Metrics
| PS Ratio | 16.77 |
| Price | 4.70 |
| Earnings Yield | -16.76% |
| Market Cap | 374.86M |